Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods:A K-COVE Study
Journal of Korean Medical Science
; : e87-2023.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-967469
Responsible library:
WPRO
ABSTRACT
National cohort data collected during the coronavirus disease 2019 (COVID-19) delta and omicron periods in Korea revealed a lower risk of severe infection in recipients of three doses of the COVID-19 vaccine (adjusted odds ratio [aOR], 0.05–0.08). The risk of death was reduced during the omicron period compared to the delta period (aOR, 0.75; 95% confidence interval, 0.67–0.84).
Full text:
Available
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Target 3.3 End transmission of communicable diseases
Health problem:
Goal 10: Communicable diseases
/
COVID-19
Database:
WPRIM (Western Pacific)
Language:
English
Journal:
Journal of Korean Medical Science
Year:
2023
Document type:
Article